Compare with Orchid Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ORCHID PHARMA - Comparison Results

ORCHID PHARMA 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES ORCHID PHARMA ALKEM LABORATORIES/
ORCHID PHARMA
 
P/E (TTM) x 24.6 -24.7 - View Chart
P/BV x 5.9 7.1 83.7% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 ALKEM LABORATORIES   ORCHID PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-20
ORCHID PHARMA
Sep-13
ALKEM LABORATORIES/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs2,720194 1,402.1%   
Low Rs1,66035 4,743.9%   
Sales per share (Unadj.) Rs697.9276.5 252.4%  
Earnings per share (Unadj.) Rs96.1-79.2 -121.3%  
Cash flow per share (Unadj.) Rs117.3-43.5 -269.9%  
Dividends per share (Unadj.) Rs25.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs515.253.9 955.2%  
Shares outstanding (eoy) m119.5770.45 169.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.10.4 757.8%   
Avg P/E ratio x22.8-1.4 -1,576.3%  
P/CF ratio (eoy) x18.7-2.6 -708.8%  
Price / Book Value ratio x4.32.1 200.2%  
Dividend payout %26.00-   
Avg Mkt Cap Rs m261,8798,067 3,246.5%   
No. of employees `00014.32.8 511.8%   
Total wages/salary Rs m15,0552,527 595.8%   
Avg. sales/employee Rs Th5,822.66,956.1 83.7%   
Avg. wages/employee Rs Th1,050.5902.5 116.4%   
Avg. net profit/employee Rs Th802.0-1,993.0 -40.2%   
INCOME DATA
Net Sales Rs m83,44419,477 428.4%  
Other income Rs m1,042407 255.9%   
Total revenues Rs m84,48619,884 424.9%   
Gross profit Rs m14,7341,103 1,336.3%  
Depreciation Rs m2,5282,519 100.3%   
Interest Rs m6515,227 12.4%   
Profit before tax Rs m12,598-6,236 -202.0%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m1,105-125 -882.4%   
Profit after tax Rs m11,493-5,580 -206.0%  
Gross profit margin %17.75.7 311.9%  
Effective tax rate %8.82.0 436.8%   
Net profit margin %13.8-28.7 -48.1%  
BALANCE SHEET DATA
Current assets Rs m54,96011,014 499.0%   
Current liabilities Rs m32,43332,060 101.2%   
Net working cap to sales %27.0-108.1 -25.0%  
Current ratio x1.70.3 493.3%  
Inventory Days Days8095 83.9%  
Debtors Days Days7234 215.0%  
Net fixed assets Rs m32,71029,440 111.1%   
Share capital Rs m239705 33.9%   
"Free" reserves Rs m61,3682,043 3,004.4%   
Net worth Rs m61,6073,800 1,621.3%   
Long term debt Rs m1,5929,018 17.7%   
Total assets Rs m99,43346,510 213.8%  
Interest coverage x20.4-0.2 -10,544.5%   
Debt to equity ratio x02.4 1.1%  
Sales to assets ratio x0.80.4 200.4%   
Return on assets %12.2-0.8 -1,606.9%  
Return on equity %18.7-146.9 -12.7%  
Return on capital %21.0-3.7 -561.3%  
Exports to sales %19.137.9 50.4%   
Imports to sales %3.022.6 13.2%   
Exports (fob) Rs m15,9177,378 215.7%   
Imports (cif) Rs m2,4834,406 56.4%   
Fx inflow Rs m16,0617,513 213.8%   
Fx outflow Rs m2,4835,649 44.0%   
Net fx Rs m13,5781,865 728.3%   
CASH FLOW
From Operations Rs m5,8511,682 347.9%  
From Investments Rs m-7,414-9,860 75.2%  
From Financial Activity Rs m7926,644 11.9%  
Net Cashflow Rs m-731-1,535 47.6%  

Share Holding

Indian Promoters % 66.9 32.3 207.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 4.6 719.6%  
FIIs % 0.0 3.3 -  
ADR/GDR % 0.0 4.6 -  
Free float % 0.0 55.3 -  
Shareholders   68,381 84,811 80.6%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   AJANTA PHARMA  GLENMARK PHARMA  AUROBINDO PHARMA  STRIDES PHARMA SCIENCE  FULFORD INDIA  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 500 Points Lower; Dow Futures Down by 77 Points(12:30 pm)

Share markets in India are presently trading on a negative note. The BSE Sensex is trading down by 553 points, down 1.1% at 47,794 levels.

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

One Chart to See Before You Sell(Fast Profits Daily)

Jan 22, 2021

In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.

Invest in the Multibaggers of 2021 and Beyond(Profit Hunter)

Jan 21, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jan 27, 2021 03:36 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS